StockData
ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V. (PRQR) stock

PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.10−0.05 (-4.35%)

Close on Nov 18, 2026Market cap $115.90MP/E –Yield –

ProQR Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ProQR Therapeutics's market cap was $134.20M on Nov 11, 2026, against $243.02M a year earlier. Over the last 5 years it ranged from $44.48M to $471.36M, with a median of $163.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$134.20M-36.0%
2025Dec 31, 2025$209.78M-2.9%
2024Dec 31, 2024$216.07M+38.4%
2023Dec 29, 2023$156.07M-40.9%
2022Dec 30, 2022$263.94M-44.0%
2021Dec 31, 2021$471.36M+127.4%
2020Dec 31, 2020$207.32M-51.5%
2019Dec 31, 2019$427.62M-25.6%
2018Dec 31, 2018$574.79M+663.4%
2017Dec 29, 2017$75.29M-34.2%
2016Dec 30, 2016$114.38M–

More ProQR Therapeutics figures

See a number that looks wrong?